PharmaSGP Holding Balance Sheet Health
Financial Health criteria checks 5/6
PharmaSGP Holding has a total shareholder equity of €44.7M and total debt of €73.2M, which brings its debt-to-equity ratio to 163.9%. Its total assets and total liabilities are €140.9M and €96.3M respectively. PharmaSGP Holding's EBIT is €26.3M making its interest coverage ratio 7.4. It has cash and short-term investments of €46.3M.
Key information
163.9%
Debt to equity ratio
€73.21m
Debt
| Interest coverage ratio | 7.4x |
| Cash | €46.27m |
| Equity | €44.67m |
| Total liabilities | €96.26m |
| Total assets | €140.93m |
Recent financial health updates
No updates
Recent updates
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings
May 06
Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio
Mar 02PharmaSGP Holding SE Just Beat Revenue Estimates By 25%
Dec 02One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically
Feb 16
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential
Jan 26Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?
Dec 04Financial Position Analysis
Short Term Liabilities: PSG's short term assets (€73.9M) exceed its short term liabilities (€29.2M).
Long Term Liabilities: PSG's short term assets (€73.9M) exceed its long term liabilities (€67.1M).
Debt to Equity History and Analysis
Debt Level: PSG's net debt to equity ratio (60.3%) is considered high.
Reducing Debt: PSG had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: PSG's debt is well covered by operating cash flow (37.8%).
Interest Coverage: PSG's interest payments on its debt are well covered by EBIT (7.4x coverage).